Suppr超能文献

在初级保健中,请求粪便免疫化学检测用于结直肠癌和炎症性肠病的诊断时,患者报告和医生报告的症状:一项前瞻性研究。

Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study.

机构信息

Department of Public Health and Clinical Medicine, Unit of Research, Education and Development - Östersund, Östersund Hospital, Umeå University, Umeå, Sweden.

Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, Umeå, Sweden.

出版信息

BMC Fam Pract. 2020 Jul 1;21(1):129. doi: 10.1186/s12875-020-01194-x.

Abstract

BACKGROUND

Rectal bleeding and a change in bowel habits are considered to be alarm symptoms for colorectal cancer and they are also common symptoms for inflammatory bowel disease. However, most patients with these symptoms do not have any of these diseases. Faecal immunochemical tests (FITs) for haemoglobin are used as triage tests in Sweden and other countries but little is known about the symptoms patients have when FITs are requested.

OBJECTIVE

Firstly, to determine patients' symptoms when FITs are used as triage tests in primary care and whether doctors record the symptoms that patients report, and secondly to evaluate the association between symptoms, FIT results and possible prediction of colorectal cancer or inflammatory bowel disease.

METHODS AND MATERIALS

This prospective study included 364 consecutive patients for whom primary care doctors requested a FIT. Questionnaires including gastrointestinal symptoms were completed by patients and doctors.

RESULTS

Concordance between symptoms reported from patients and doctors was low. Rectal bleeding was recorded by 43.5% of patients versus 25.6% of doctors, FITs were negative in 58.3 and 52.7% of these cases respectively. The positive predictive value (PPV) of rectal bleeding recorded by patients for colorectal cancer or inflammatory bowel disease was 9.9% (95% confidence interval [CI] 5.2-14.7); for rectal bleeding combined with a FIT the PPV was 22.6% (95% CI 12.2-33.0) and the negative predictive value (NPV) was 98.9% (95% CI 96.7-100). For patient-recorded change in bowel habits the PPV was 6.1% (95% CI 2.4-9.8); for change in bowel habits combined with a FIT the PPV was 18.2% (95% CI 9.1-30.9) and the NPV 100% (95% CI 90.3-100).

CONCLUSIONS

Doctors should be aware that, during consultations, they do not record all symptoms experienced by patients. FITs requested in primary care, when found positive, may potentially be of help in prioritising referrals, also when patients present with rectal bleeding or change in bowel habits.

摘要

背景

直肠出血和排便习惯改变被认为是结直肠癌的警报症状,也是炎症性肠病的常见症状。然而,大多数出现这些症状的患者并没有这些疾病。粪便免疫化学检测(FIT)用于血红蛋白作为瑞典和其他国家的分诊检测,但对于要求进行 FIT 检测的患者的症状知之甚少。

目的

首先,确定在初级保健中使用 FIT 进行分诊检测时患者的症状,以及医生是否记录患者报告的症状,其次评估症状、FIT 结果与结直肠癌或炎症性肠病的可能预测之间的关联。

方法和材料

这项前瞻性研究纳入了 364 名连续就诊的患者,他们的初级保健医生要求进行 FIT 检测。患者和医生完成了包括胃肠道症状在内的问卷。

结果

患者报告的症状与医生记录的症状之间的一致性较低。43.5%的患者报告直肠出血,而医生记录的比例为 25.6%,在这些患者中,FIT 结果分别为阴性和 52.7%。患者报告的直肠出血对结直肠癌或炎症性肠病的阳性预测值(PPV)为 9.9%(95%置信区间 [CI] 5.2-14.7);将直肠出血与 FIT 结合的 PPV 为 22.6%(95% CI 12.2-33.0),阴性预测值(NPV)为 98.9%(95% CI 96.7-100)。患者记录的排便习惯改变的 PPV 为 6.1%(95% CI 2.4-9.8);将排便习惯改变与 FIT 结合的 PPV 为 18.2%(95% CI 9.1-30.9),NPV 为 100%(95% CI 90.3-100)。

结论

医生应该意识到,在就诊过程中,他们没有记录患者的所有症状。在初级保健中要求进行的 FIT,如果结果阳性,可能有助于优先安排转诊,当患者出现直肠出血或排便习惯改变时尤其如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792c/7331274/6b93f087a5bb/12875_2020_1194_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验